Capital & Planning LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.3M Buy
11,522
+249
+2% +$294K 6.6% 5
2026
Q2
$13.5M Buy
11,273
+401
+4% +$410K 6.98% 6
2026
Q1
$10M Buy
10,872
+8,372
+335% +$8.49M 6.07% 6
2025
Q4
$2.69M Sell
2,500
-8,611
-77% -$8.23M 12.44% 5
2025
Q3
$8.48M Buy
11,111
+583
+6% +$434K 5.24% 6
2025
Q2
$8.21M Buy
10,528
+91
+0.9% +$70.7K 5.57% 6
2025
Q1
$8.62M Buy
10,437
+534
+5% +$444K 6.4% 6
2024
Q4
$7.65M Buy
+9,903
New +$8.2M 5.59% 6

Other funds holding LLY

Capital & Planning LLC's LLY Position: Q3 2026 in Review

Capital & Planning LLC increased its Eli Lilly (LLY) stake by 2.2% in Q3 2026, buying an estimated $294K and bringing the position to 11,522 shares worth $13.3M. The position accounts for 6.6% of the portfolio, ranked #5.

Capital & Planning LLC first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $13.5M in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Capital & Planning LLC held 11,522 shares of Eli Lilly worth $13.3M as of Q3 2026.
  • Capital & Planning LLC bought 249 Eli Lilly shares in Q3 2026, an estimated $294K.
  • Eli Lilly made up 6.6% of Capital & Planning LLC's portfolio in Q3 2026, its #5 holding.
  • Capital & Planning LLC first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Capital & Planning LLC's Eli Lilly position peaked at $13.5M in Q2 2026.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Capital & Planning LLC's 13F filing for Q3 2026, filed 16 Nov 2026.